Although our previous chordoma modeling used twhh:Gal4 as transgene driver, based on the twhh promoter region with promiscuous transcriptional activity in notochord cells (Burger et al., 2014; Du and Dienhart, 2001), we aimed for a stronger driver that would also enable injection-based oncogene testing. The gene discussed is LGALS4; the disease is chordoma.